CN Patent

CN103384669A — Alk的二环抑制剂

Assigned to AbbVie Inc · Expires 2013-11-06 · 13y expired

What this patent protects

本发明涉及式（I）的化合物或药学上可接受的盐， 其中R 1 、R 2 、R 3 、X、Y、Z、A、B、G 1 、m和n在说明书中定义。本发明还涉及包含用于抑制激酶如ALK的所述化合物的组合物以及治疗疾病如癌的方法。

USPTO Abstract

本发明涉及式（I）的化合物或药学上可接受的盐， 其中R 1 、R 2 、R 3 、X、Y、Z、A、B、G 1 、m和n在说明书中定义。本发明还涉及包含用于抑制激酶如ALK的所述化合物的组合物以及治疗疾病如癌的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103384669A
Jurisdiction
CN
Classification
—
Expires
2013-11-06
Drug substance claim
No
Drug product claim
No
Assignee
AbbVie Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.